Here is the exact HTML formatted press release content for the Transthyretin Amyloidosis (ATTR) Market as requested: According to a newly published market research report by 24LifeSciences, the global Transthyretin Amyloidosis (ATTR) market was valued at USD 3.2 billion in 2024 and is projected to reach USD 6.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 11.3% during the...